Published in Can Fam Physician on June 01, 1985
Pneumococcal Vaccine And Hodgkin's Disease. Can Fam Physician (1985) 0.75
Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med (1970) 5.03
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer (1975) 2.52
Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med (1977) 1.93
Childhood social environment and Hodgkin's disease. N Engl J Med (1981) 1.77
Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep (1982) 1.51
Reed-Sternberg-like cells in infectious mononucleosis. Lancet (1969) 1.49
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Epidemiology of Hodgkin's disease. Semin Oncol (1980) 1.33
Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med (1979) 1.28
Post-treatment laparotomy in the management of Hodgkin's disease. Lancet (1978) 1.23
The significance of mediastinal involvement in early stage Hodgkin's disease. Cancer (1978) 1.05
Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results. Cancer Treat Rep (1982) 1.05
Hodgkin's disease. N Engl J Med (1979) 1.03
Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Ann Intern Med (1982) 1.01
Staging of Hodgkin's disease: a surgical perspective. Am J Surg (1976) 0.93
Histopathologic review of lymphoma cases from the Southwest Oncology Group. Cancer (1977) 0.90
Routine full-lung tomography in the initial staging and treatment planning of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Cancer (1976) 0.85
Importance of staging in Hodgkin's disease. Semin Oncol (1980) 0.83
Chemotherapy in the treatment of Hodgkin's disease. Semin Hematol (1983) 0.80
Hodgkin's disease. Med Clin North Am (1984) 0.79
The nurse's role in screening and cancer detection. Semin Oncol (1980) 0.79
Importance of substaging of stage III Hodgkin's disease. Semin Oncol (1980) 0.78
Roentgenologic aspects of Hodgkin's disease. I. Current role of lymphangiography . Natl Cancer Inst Monogr (1973) 0.78
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet (2000) 2.74
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med (1990) 2.63
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood (1991) 2.54
Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49
Two patterns of perinatal brain damage and their conditions of occurrence. Am J Obstet Gynecol (1972) 2.37
Establishing a therapeutic range for heparin therapy. Ann Intern Med (1993) 2.31
Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review. Ann Intern Med (1992) 2.23
Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors. Antimicrob Agents Chemother (1995) 2.21
Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev (1997) 2.13
Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med (2000) 2.12
Real-world variability in dabigatran levels in patients with atrial fibrillation. J Thromb Haemost (2015) 2.07
Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med (1998) 2.03
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing. Ann Intern Med (2001) 1.93
Experimental carbon monoxide encephalopathy in the primate I. Physiologic and metabolic aspects. Arch Neurol (1974) 1.90
Does this patient have deep vein thrombosis? JAMA (1998) 1.90
Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke (1996) 1.79
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med (1998) 1.76
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med (2000) 1.70
Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med (2001) 1.70
Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med (2001) 1.68
Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost (2008) 1.67
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA (1998) 1.67
Nervous system effects of cardiac arrest in monkeys. Preservation of vision. Arch Neurol (1977) 1.63
Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA (1999) 1.61
A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost (2006) 1.59
The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med (1998) 1.58
Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Thromb Haemost (2001) 1.58
Efficacious experimental stroke treatment with high-dose methylprednisolone. Stroke (1994) 1.51
A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same. Ann Behav Med (2011) 1.46
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med (1996) 1.45
Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thromb Haemost (1991) 1.45
Experimental carbon monoxide encephalopathy in the primate. II. Clinical aspects, neuropathology, and physiologic correlation. Arch Neurol (1974) 1.44
HIV type 1 protease cleavage site mutations and viral fitness: implications for drug susceptibility phenotyping assays. AIDS Res Hum Retroviruses (2000) 1.41
The ontogenesis of haematoencephalic cation transport processes in the rhesus monkey. J Physiol (1970) 1.32
Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost (1999) 1.31
Venous thromboembolism in patients undergoing rehabilitation for stroke. Arch Phys Med Rehabil (1992) 1.26
Some reasons for compliance and noncompliance in a health maintenance organization breast cancer screening program. J Compliance Health Care (1988) 1.25
Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med (1992) 1.24
Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med (2000) 1.24
Topography of lesions in newborn and infant brains following cardiac arrest and resuscitation. Damage to brain and hemispheres. Biol Neonate (1976) 1.23
Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient. Haemostasis (2000) 1.22
Four patterns of perinatal brain damage and their conditions of occurrence in primates. Adv Neurol (1975) 1.21
Hypoglycemic brain injury: potentiation from respiratory depression and injury aggravation from hyperglycemic treatment overshoots. J Cereb Blood Flow Metab (2000) 1.18
Distribution of corpus callosum and anterior commissure in cat and raccoon. J Comp Neurol (1965) 1.18
Fetal growth retardation in rats from different levels of hypoxia. Biol Neonate (1986) 1.16
Central nervous system findings in the newborn monkey following severe in utero partial asphyxia. Neurology (1975) 1.15
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost (2004) 1.14
Biopsychosocial aspects of prostate cancer. Psychosomatics (2000) 1.14
Early metabolic alterations in edematous perihematomal brain regions following experimental intracerebral hemorrhage. J Neurosurg (1998) 1.13
Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med (1992) 1.10
Neuropathology of systemic circulatory arrest in adult monkeys. Neurology (1972) 1.09
A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med (1994) 1.08
Experimental infection of rhesus with simian virus 40 (SV40). Proc Soc Exp Biol Med (1969) 1.08
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost (2005) 1.06
Perinatal asphyxia, causes, detection and neurologic sequelae. Pediatr Clin North Am (1973) 1.06
Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med (1998) 1.06
Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost (2011) 1.06
Depression in Korean immigrants with hepatitis B and related liver diseases. Psychosomatics (2001) 1.06
Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol (1985) 1.04
Comparative neurology of vocalization and speech: proof of a dichotomy. Ann N Y Acad Sci (1976) 1.02
Reasons for non-entry in randomized clinical trials for breast cancer: a single institutional study. J Surg Oncol (1992) 1.02
The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc (1997) 1.01
Factors associated with perceived risk in automotive employees at increased risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.01
Cystic brain alteration after incomplete placental abruption in monkey. Arch Neurol (1969) 1.01
Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma. Cancer Res (1986) 1.01
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med (1992) 1.00
The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost (1991) 1.00
The role of D-dimer in the diagnosis of venous thromboembolism. Curr Opin Pulm Med (1997) 0.99
Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial. J Thromb Haemost (2015) 0.99
Effects upon the fetus of oxygen administration to the mother. A study in monkey. Acta Obstet Gynecol Scand (1977) 0.99
A latex D-dimer reliably excludes venous thromboembolism. Arch Intern Med (2001) 0.97
Fatal strokes in hyperglycemic cats. Stroke (1989) 0.97
Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med (2002) 0.97
The effect of pentobarbital anesthesia on resuscitation and brain damage in fetal rhesus monkeys asphyxiated on delivery. J Pediatr (1969) 0.97
Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy. Blood Coagul Fibrinolysis (2002) 0.97
The topography of impaired microvascular perfusion in the primate brain following total circulatory arrest. Neurology (1972) 0.96
Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med (2000) 0.94
Neural control of social behavior: prefrontal and anterior temporal cortex. Neuropsychologia (1973) 0.94
Comparison of the Villalta and Ginsberg clinical scales to diagnose the post-thrombotic syndrome: correlation with patient-reported disease burden and venous valvular reflux. J Thromb Haemost (2006) 0.94
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study. J Thromb Haemost (2005) 0.94
Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Ann Intern Med (1998) 0.93
D-dimer testing in pregnant patients: towards determining the next 'level' in the diagnosis of deep vein thrombosis. J Thromb Haemost (2010) 0.93
The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. Arch Intern Med (1998) 0.93
Uncus and amygdala lesions: effects on social behavior in the free-ranging rhesus monkey. Science (1968) 0.93
Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke (1988) 0.92
Uses of heparin. Ancrod for heparin induced thrombocytopenia. BMJ (1993) 0.92
Predictability of the state of fetal oxygenation from a quantitative analysis of the components of late deceleration. Am J Obstet Gynecol (1973) 0.92
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study. J Thromb Haemost (2003) 0.92
Effect of warfarin on activated partial thromboplastin time in patients receiving heparin. Arch Intern Med (1998) 0.92
Production of fetal asphyxia by maternal psychological stress. Pavlov J Biol Sci (1977) 0.91
Fetal brain injury after maternal carbon monoxide intoxication. Clinical and neuropathologic aspects. Neurology (1976) 0.91
The clinical utility of a rapid bedside D-dimer assay for screening of deep vein thrombosis following orthopaedic surgery. Thromb Haemost (1997) 0.90
Fetal asphyxia due to umbilical cord compression. Metabolic and brain pathologic consequences. Biol Neonate (1975) 0.90
The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study. Thromb Haemost (1996) 0.90
Neurological effects of systemic circulatory arrests in the monkey. Neurology (1970) 0.90